QUIANA SANCHEZ: Open Payments
NPI 1619693231 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 31 payments from 8 companies in 2025. Trend: 2023 $45 · 2024 $0 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $353 |
| Merck Sharp & Dohme LLC | 8 | $177 |
| ABBVIE INC. | 4 | $106 |
| Novartis Pharmaceuticals Corporation | 3 | $92 |
| Gilead Sciences, Inc. | 2 | $51 |
| Caris MPI, Inc. | 2 | $40 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $23 |
| Daiichi Sankyo Inc. | 1 | $22 |
Products named: LYNPARZA, ELAHERE, ENHERTU, KISQALI, KEYTRUDA, MI CANCER SEEK, NERLYNX.
Industry payments across CA — which companies pay providers there.
